Skip directly to content

2017 Pipeline Report

July 5, 2017

HIV, TB, and HCV

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development

Written by Mike Frick, Annette Gaudino, Mark Harrington, Tim Horn, Richard Jefferys, Jeremiah Johnson, Erica Lessem, Marcus Low, and Lindsay McKenna

In this year's report:

Introduction and Executive Summary (HTML)
PDF

Mark Harrington

The Antiretroviral Pipeline (HTML)
PDF

Tim Horn

Preventive Technologies: Antiretroviral and Vaccine Development (HTML)
PDF

Jeremiah Johnson & Richard Jefferys

Research Toward a Cure and Immune-Based and Gene Therapies (HTML)
PDF

Richard Jefferys

The Tuberculosis Diagnostics Pipeline (HTML)
PDF
Erica Lessem

The Tuberculosis Prevention Pipeline (HTML)
PDF

Mike Frick

The Tuberculosis Treatment Pipeline: A Breakthrough Year for the Treatment of XDR-TB (HTML)
PDF

Marcus Low

The Tuberculosis Diagnostics and Treatment Pipeline for Children (HTML)
PDF

Lindsay McKenna

HCV Pipeline: DAAs and Diagnostics in the Pangenotypic Era (HTML)
PDF
Annette Gaudino